Methylation of estrogen and progesterone receptor gene 5′ CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors

Clinical Cancer Research

Volumn 2, Issue 5, 1996, Pages 805-810

  Lapidus, Rena G ^a   Ferguson, Anne T ^a   Ottaviano, Yvonne L ^a   Parl, Fritz F ^b   Smith, Helene S ^c   Weitzman, Sigmund A ^d   Baylin, Stephen B ^a   Issa, Jean Pierre J ^a   Davidson, Nancy E ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLATION; PRIORITY JOURNAL;

BREAST NEOPLASMS; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION; HUMANS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR CELLS, CULTURED;

EID: 0029934262     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. McGuire, W. L. Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin. Oncol., 5: 428-433, 1978.
2. Read, L. D., Snider, C. E., Miller, J. S., Greene, G. L., and Katzenellenbogen, B. S. Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Mol. Endocrinol., 2: 263-271, 1988.
3. Roodi, N., Bailey, R., Kao, W-Y., Verrier, C. S., Yee, C. J., Dupont, W. D., and Parl, F. F. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J. Natl. Cancer Inst., 87: 446-451, 1995.
4. Yaich, L., Dupont, W. D., Cavener, D. R., and Parl, F. F. Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res., 52: 77-83, 1992.
5. Fuqua, S. A. W., Allred, D. C., Elledge, R. M., Krieg, S. L., Benedix, M. G., Nawa, Z., O'Malley, B. W., Greene, G. L., and McGuire, W. L. The ER-positive/PR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain. Breast Cancer Res. Treat., 26: 191-202, 1993.
6. Fuqua, S. A. W., Hill, S. M., Chamness, G. C., Benedix, M. G., Greene, G. L., O'Malley, B. W., and McGuire, W. L. Progesterone receptor gene restriction fragment length polymorphisms in human breast tumors. J. Natl. Cancer Inst., 83: 1157-1160, 1991.
7. Bird, A. P. CpG-rich island and the function of DNA methylation. Nature (Lond.), 321: 203-213, 1986.
8. Mohandas, T., Sparkes, R. S., and Shapiro, L. J. Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science (Washington, DC), 211: 393-396, 1981.
9. Li, E., Beard, C., and Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature (Lond.), 366, 362-365, 1993.
10. Antequera, R., Boyes, J., and Bird, A. P. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell, 62: 503-514, 1990.
11. Ottaviano, Y. L , Issa, J-P., Parl, F. F., Smith, H. S., Baylin, S. B., and Davidson, N. E. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res., 54: 2552-2555, 1994.
12. Jones, P. A. Altering gene expression with 5-azacytidine. Cell, 40: 485-496, 1985.
13. Ferguson, A. T., Lapidus, R. G., Baylin, S. B., and Davidson, N. E. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res., 55: 2279-2283, 1995.
14. Parl, F. F., Cavener, W D., and Dupont, W. D. Genomic DNA analysis of estrogen receptor in breast cancer. Breast Cancer Res. Treat., 14: 57-64, 1988.
15. Bergstraesser, L. M., and Weitzman, S. A. Culture of normal and malignant primary human mammary epithelial cells in a physiological manner simulates in vivo growth patterns and allows discrimination of cell type. Cancer Res., 53: 2644-2654, 1993.
16. Celano, P., Baylin, S. B., and Casero, R. A. Polyamines differentially modulate the transcription of growth associated genes in human colon carcinoma cells. J. Biol. Chem., 264: 8922-8927, 1989.
17. Green S., Walter, P., Kumar, V., Krust, A., Borner, J-M., Argos, P., and Chambon, P. Human oestrogen receptor cDNA: sequence, expression and homology 10 v-erb-A. Nature (Lond), 320: 134-139, 1986.
18. Piva, R., Rimondi, A. P., Hanau, S., Maestri, I., Alvisi, A., Kumar, V. L., and del Senno, L. Different methylation of oestrogen receptor DNA in human breast carcinomas with and without oestrogen receptor. Br. J. Cancer. 61: 270-275, 1990.
19. Kastner, L., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., and Chambon, P Two distinct estrogen-regulated promoters generate transcripts encoding two functionally different human progesterone receptor forms A and B. EMBO J., 9: 1603-1614, 1990.
20. Misrahi, M , Venecie, P., Saugier-Veber, P., Sar, S., Dessen, P., and Milgrom, E. Structure of the human progesterone receptor gene. Biochim. Biophys. Acta. 1216: 289-292, 1993.
21. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., Linehan, W. M., and Baylin, S. B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA. 91: 9700-9704, 1994.
22. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J-P., Davidson, N. E., Sidransky, D., and Baylin, S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55: 4525-4530, 1995
23. Graff, J. G., Herman, J. G., Lapidus, R. G., E-Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E., and Baylin, S. B. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinoma. Cancer Res., 55: 5195-5199, 1995.
24. Boyes, J., and Bird, A. Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence of involvement of a methyl-CpG binding protein. EMBO J., 11: 327-333, 1992.
25. Brandeis, M., Frank, D., Keshet, I., Siegfried, Z. Medelsohn, M., Nemes, A., Temper, B., Razin, A., and Ceder. H Sp1 elements protect a CpG island from de novo methylation. Nature (Lond.), 371: 435-438, 1994.
26. Antequera, F., Boyes, J., and Bird, A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell, 62: 503-514, 1990.
27. Hsieh, C. Dependence of transcriptional repression on CpG methylation density. Mol. Cell. Biol., 14: 5487-5494, 1994.